Building a national drugs observatory — toolbox

Return to 'Building a national drugs observatory: a joint handbook'

Summary

This toolbox provides a range of complementary tools, templates and information to enhance the content of the handbook. For ease of reference, these have been divided into five sections.

If you need more information, or wish to add to the tools, make observations or recommendations, please contact the EMCDDA or CICAD at the following addresses:

Handbook_NDO@emcdda.europa.eu and OID_CICAD@oas.org

Online toolbox

The toolbox provides access to a range of material related to the national drugs observatory toolbox. New resources will be added as they arrive.

Guidelines and templates

As a support to the further development of this toolbox, here are some working documents that may be useful. We kindly invite you to send us any translation or any other guidelines or template documents that you may find complement the selection we have provided.

EMCDDA related tools

This section provides shows links to other EMCDDA tools and products that help complement certain aspects of the handbook. Please click on the link to access the source.

Complementary information

UN Conventions

International Organisations

Further reading

Drug epidemiology

  • EMCDDA (2000), Understanding and responding to drug use: the role of qualitative research. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
  • EMCDDA (1997),  Estimating the prevalence of problem drug use in Europe. EMCDDA. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
  • Griffiths, P., Vingoe, L., Hunt, N., Mounteney, J. & Hartnoll, R. (2000), Drug information systems, early warning and new trends: Can drug monitoring systems become more sensitive to emerging trends in drug consumption? Substance Use and Misuse, 35, 811-844.
  • Hartnoll, R. (2003), Drug epidemiology in the European institutions: historical background and key indicators. Bulletin on Narcotics, 55 1&2, 53-71.
  • Hartnoll, R., Hendriks, V., Morrival, M. (1998). The assessment of drug problems. Copenhagen: WHO Regional Office for Europe.
  • Mounteney, J., Fry, C., McKeganey, N. & Haugland, S. (2010). Challenges of reliability and validity in the identification and monitoring of emerging drug trends. Substance Use Misuse. 45:266–287.
  • Sloboda Z, ed. (2005) Epidemiology of drug abuse. New York: Springer. Science & Business Media.
  • Sloboda, Z., Kozel, N. (2003). Understanding drug trends in the USA: the role of the community epidemiology work group as part of a comprehensive drug information system. Bulletin on Narcotics, LV(1&2):1–13.

Research methods

  • Babbie, E. (1990) Survey Research Methods. 2nd edn. Belmont CA: Wadsworth publishing company.
  • Bryman, A. (2004) Social Research Methods. New York: OUP.
  • Creswell, J. (2003). Research design. Qualitative, quantitative and mixed method approaches. Thousand Oaks, CA: Sage.
  • Kirk, J., Miller, M. (1986). Reliability and validity in qualitative research. Beverly Hills, CA: Sage.
  • Levy, P. & Lemeshow, S. (1999) Sampling of populations: Methods and Applications., 3rd edn. New York: Wiley.
  • Miller, P.G., Strang, J., & Miller, P.M. (Eds.) Addiction Research Methods. Oxford, England: Wiley-Blackwell, 2010.
  • Banks, G. (2009), ‘Evidence-based policy making. What is it? How do we get it?’, ANU (write in full) Public Lecture Series, presented by ANZSOG, Canberra, February 2009.
  • Hallam, C. and Bewley-Taylor, D. (2010), ‘Drug use: Knowledge, culture and context’, The Beckley Foundation Drug Policy Programme, Briefing Paper Twenty-One, January 2010.
  • Sutcliffe, S. and Court, J. (2005), ‘Evidence-based policy making: What is it? How does it work? What relevance for developing countries?’, Overseas Development Institute.
  • Davies, P. (2004), ‘Is evidence-based government possible?’, Jerry Lee Lecture, Fourth Annual Campbell Collaboration Colloquium, Washington D.C.

Additional resources

  • Methodological material — Guidelines for the modeling of statistical data and metadata — United Nations Statistical Commission and Economic Commission for Europe — Conference of European Statisticians, United Nations, Geneva, 1995.
  • Outcome of the round table on current and emerging challenges, new trends and patterns of the world drug problem and possible improvements to the evaluation
  • system, submitted by the Chairperson of the round table, Audronė Astrauskienė (Lithuania) — Commission on Narcotic Drugs Fifty-second session Vienna, 11–20 March 2009 — Agenda item 13 (a) Round-table discussions of the high-level segment: current and emerging challenges, new trends and patterns of the world drug problem and possible improvements to the evaluation system.
  • Commission on Narcotic Drugs, Report on the fifty-second session (14 March 2008 and
  • 11–20 March 2009), Economic and Social Council, Official Records, 2009 — Supplement No 8.
  • UNODC expert group meeting on global drug data collection, analysis and reporting: Summary of meeting and major recommendations, 6–8 July 2009, Vienna International Centre, Vienna, Austria.

Group attachments

Downloads
Top